nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—UGT1A1—Sorafenib—thyroid cancer	0.561	1	CbGbCtD
Testosterone Propionate—Endocrine disorder—Vandetanib—thyroid cancer	0.00851	0.0254	CcSEcCtD
Testosterone Propionate—Oligospermia—Epirubicin—thyroid cancer	0.00839	0.0251	CcSEcCtD
Testosterone Propionate—Oligospermia—Doxorubicin—thyroid cancer	0.00776	0.0232	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—NCOA4—thyroid cancer	0.00744	0.0712	CbGpPWpGaD
Testosterone Propionate—Azoospermia—Epirubicin—thyroid cancer	0.00653	0.0195	CcSEcCtD
Testosterone Propionate—Neoplasm—Vandetanib—thyroid cancer	0.00638	0.019	CcSEcCtD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—TRIM24—thyroid cancer	0.00631	0.0604	CbGpPWpGaD
Testosterone Propionate—Azoospermia—Doxorubicin—thyroid cancer	0.00604	0.018	CcSEcCtD
Testosterone Propionate—Endocrine disorder—Sorafenib—thyroid cancer	0.00574	0.0171	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—NCOA4—thyroid cancer	0.0055	0.0526	CbGpPWpGaD
Testosterone Propionate—Dermatitis bullous—Vandetanib—thyroid cancer	0.00536	0.016	CcSEcCtD
Testosterone Propionate—AR—Nuclear Receptors—THRB—thyroid cancer	0.00531	0.0508	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—CITED1—thyroid cancer	0.00529	0.0506	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal haemorrhage—Vandetanib—thyroid cancer	0.00512	0.0153	CcSEcCtD
Testosterone Propionate—CYP17A1—Endogenous sterols—RXRA—thyroid cancer	0.00478	0.0458	CbGpPWpGaD
Testosterone Propionate—Neoplasm—Sorafenib—thyroid cancer	0.0043	0.0128	CcSEcCtD
Testosterone Propionate—Gynaecomastia—Sorafenib—thyroid cancer	0.00426	0.0127	CcSEcCtD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00419	0.0401	CbGpPWpGaD
Testosterone Propionate—Dysuria—Vandetanib—thyroid cancer	0.00414	0.0124	CcSEcCtD
Testosterone Propionate—Haematuria—Vandetanib—thyroid cancer	0.00376	0.0112	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00373	0.0111	CcSEcCtD
Testosterone Propionate—Haemoglobin—Vandetanib—thyroid cancer	0.00356	0.0106	CcSEcCtD
Testosterone Propionate—Haemorrhage—Vandetanib—thyroid cancer	0.00354	0.0106	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Vandetanib—thyroid cancer	0.0035	0.0104	CcSEcCtD
Testosterone Propionate—Urethral disorder—Vandetanib—thyroid cancer	0.00347	0.0104	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—CHST14—thyroid cancer	0.00338	0.0324	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CHST14—thyroid cancer	0.00324	0.031	CbGpPWpGaD
Testosterone Propionate—Angiopathy—Vandetanib—thyroid cancer	0.00321	0.0096	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Vandetanib—thyroid cancer	0.00319	0.00953	CcSEcCtD
Testosterone Propionate—Vesiculobullous rash—Epirubicin—thyroid cancer	0.00314	0.00937	CcSEcCtD
Testosterone Propionate—Alopecia—Vandetanib—thyroid cancer	0.00313	0.00935	CcSEcCtD
Testosterone Propionate—Breast disorder—Sorafenib—thyroid cancer	0.00312	0.00932	CcSEcCtD
Testosterone Propionate—Mental disorder—Vandetanib—thyroid cancer	0.0031	0.00927	CcSEcCtD
Testosterone Propionate—Malnutrition—Vandetanib—thyroid cancer	0.00308	0.00921	CcSEcCtD
Testosterone Propionate—Vesiculobullous rash—Doxorubicin—thyroid cancer	0.0029	0.00867	CcSEcCtD
Testosterone Propionate—Erectile dysfunction—Sorafenib—thyroid cancer	0.00275	0.00821	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF7L1—thyroid cancer	0.0027	0.0258	CbGpPWpGaD
Testosterone Propionate—Hypertension—Vandetanib—thyroid cancer	0.00266	0.00795	CcSEcCtD
Testosterone Propionate—Arthralgia—Vandetanib—thyroid cancer	0.00262	0.00784	CcSEcCtD
Testosterone Propionate—Anxiety—Vandetanib—thyroid cancer	0.00262	0.00781	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00261	0.00778	CcSEcCtD
Testosterone Propionate—Seborrhoeic dermatitis—Epirubicin—thyroid cancer	0.00258	0.0077	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00252	0.00752	CcSEcCtD
Testosterone Propionate—Oedema—Vandetanib—thyroid cancer	0.00252	0.00751	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Vandetanib—thyroid cancer	0.00247	0.00737	CcSEcCtD
Testosterone Propionate—Skin disorder—Vandetanib—thyroid cancer	0.00244	0.0073	CcSEcCtD
Testosterone Propionate—Haemoglobin—Sorafenib—thyroid cancer	0.0024	0.00717	CcSEcCtD
Testosterone Propionate—Haemorrhage—Sorafenib—thyroid cancer	0.00239	0.00714	CcSEcCtD
Testosterone Propionate—Seborrhoeic dermatitis—Doxorubicin—thyroid cancer	0.00239	0.00713	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Sorafenib—thyroid cancer	0.00236	0.00705	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Sorafenib—thyroid cancer	0.00235	0.00701	CcSEcCtD
Testosterone Propionate—Urethral disorder—Sorafenib—thyroid cancer	0.00234	0.00699	CcSEcCtD
Testosterone Propionate—UGT1A1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.0023	0.022	CbGpPWpGaD
Testosterone Propionate—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00229	0.00685	CcSEcCtD
Testosterone Propionate—Insomnia—Vandetanib—thyroid cancer	0.00228	0.0068	CcSEcCtD
Testosterone Propionate—Paraesthesia—Vandetanib—thyroid cancer	0.00226	0.00675	CcSEcCtD
Testosterone Propionate—AR—Nuclear Receptors—RXRA—thyroid cancer	0.00225	0.0216	CbGpPWpGaD
Testosterone Propionate—Dyspnoea—Vandetanib—thyroid cancer	0.00224	0.0067	CcSEcCtD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00222	0.0213	CbGpPWpGaD
Testosterone Propionate—Rash pustular—Epirubicin—thyroid cancer	0.0022	0.00658	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00217	0.00649	CcSEcCtD
Testosterone Propionate—Fatigue—Vandetanib—thyroid cancer	0.00217	0.00648	CcSEcCtD
Testosterone Propionate—Angiopathy—Sorafenib—thyroid cancer	0.00217	0.00647	CcSEcCtD
Testosterone Propionate—Immune system disorder—Sorafenib—thyroid cancer	0.00216	0.00644	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Sorafenib—thyroid cancer	0.00215	0.00643	CcSEcCtD
Testosterone Propionate—Pain—Vandetanib—thyroid cancer	0.00215	0.00643	CcSEcCtD
Testosterone Propionate—Alopecia—Sorafenib—thyroid cancer	0.00211	0.00631	CcSEcCtD
Testosterone Propionate—Mental disorder—Sorafenib—thyroid cancer	0.00209	0.00625	CcSEcCtD
Testosterone Propionate—Malnutrition—Sorafenib—thyroid cancer	0.00208	0.00621	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00206	0.00614	CcSEcCtD
Testosterone Propionate—Rash pustular—Doxorubicin—thyroid cancer	0.00204	0.00609	CcSEcCtD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CHST14—thyroid cancer	0.00203	0.0194	CbGpPWpGaD
Testosterone Propionate—Breast pain—Epirubicin—thyroid cancer	0.00202	0.00602	CcSEcCtD
Testosterone Propionate—Jaundice cholestatic—Epirubicin—thyroid cancer	0.002	0.00598	CcSEcCtD
Testosterone Propionate—Abdominal pain—Vandetanib—thyroid cancer	0.00199	0.00594	CcSEcCtD
Testosterone Propionate—Breast pain—Doxorubicin—thyroid cancer	0.00186	0.00557	CcSEcCtD
Testosterone Propionate—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.00185	0.00553	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00184	0.0176	CbGpPWpGaD
Testosterone Propionate—Inflammation—Epirubicin—thyroid cancer	0.00181	0.00541	CcSEcCtD
Testosterone Propionate—Asthenia—Vandetanib—thyroid cancer	0.00181	0.00539	CcSEcCtD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.0018	0.0172	CbGpPWpGaD
Testosterone Propionate—Hypertension—Sorafenib—thyroid cancer	0.0018	0.00536	CcSEcCtD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00178	0.017	CbGpPWpGaD
Testosterone Propionate—Pruritus—Vandetanib—thyroid cancer	0.00178	0.00532	CcSEcCtD
Testosterone Propionate—Arthralgia—Sorafenib—thyroid cancer	0.00177	0.00529	CcSEcCtD
Testosterone Propionate—Myalgia—Sorafenib—thyroid cancer	0.00177	0.00529	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00176	0.00525	CcSEcCtD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—RXRA—thyroid cancer	0.00173	0.0165	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Vandetanib—thyroid cancer	0.00172	0.00514	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00171	0.0164	CbGpPWpGaD
Testosterone Propionate—Anaphylactic shock—Sorafenib—thyroid cancer	0.0017	0.00507	CcSEcCtD
Testosterone Propionate—Inflammation—Doxorubicin—thyroid cancer	0.00168	0.00501	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Sorafenib—thyroid cancer	0.00166	0.00497	CcSEcCtD
Testosterone Propionate—Dizziness—Vandetanib—thyroid cancer	0.00166	0.00497	CcSEcCtD
Testosterone Propionate—Skin disorder—Sorafenib—thyroid cancer	0.00165	0.00492	CcSEcCtD
Testosterone Propionate—Vomiting—Vandetanib—thyroid cancer	0.0016	0.00478	CcSEcCtD
Testosterone Propionate—Neoplasm—Epirubicin—thyroid cancer	0.00159	0.00475	CcSEcCtD
Testosterone Propionate—Rash—Vandetanib—thyroid cancer	0.00159	0.00474	CcSEcCtD
Testosterone Propionate—Dermatitis—Vandetanib—thyroid cancer	0.00159	0.00473	CcSEcCtD
Testosterone Propionate—Headache—Vandetanib—thyroid cancer	0.00158	0.00471	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00155	0.00462	CcSEcCtD
Testosterone Propionate—Dyspnoea—Sorafenib—thyroid cancer	0.00151	0.00452	CcSEcCtD
Testosterone Propionate—Nausea—Vandetanib—thyroid cancer	0.00149	0.00446	CcSEcCtD
Testosterone Propionate—Neoplasm—Doxorubicin—thyroid cancer	0.00147	0.00439	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00147	0.00438	CcSEcCtD
Testosterone Propionate—Fatigue—Sorafenib—thyroid cancer	0.00146	0.00437	CcSEcCtD
Testosterone Propionate—Pain—Sorafenib—thyroid cancer	0.00145	0.00433	CcSEcCtD
Testosterone Propionate—AR—Nuclear Receptors—PPARG—thyroid cancer	0.00142	0.0136	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—HIF1A—thyroid cancer	0.00141	0.0135	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00139	0.00415	CcSEcCtD
Testosterone Propionate—Increased appetite—Epirubicin—thyroid cancer	0.00136	0.00406	CcSEcCtD
Testosterone Propionate—Urticaria—Sorafenib—thyroid cancer	0.00135	0.00403	CcSEcCtD
Testosterone Propionate—Abdominal pain—Sorafenib—thyroid cancer	0.00134	0.00401	CcSEcCtD
Testosterone Propionate—Dermatitis bullous—Epirubicin—thyroid cancer	0.00134	0.00399	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00132	0.00394	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00128	0.00381	CcSEcCtD
Testosterone Propionate—Increased appetite—Doxorubicin—thyroid cancer	0.00126	0.00375	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Sorafenib—thyroid cancer	0.00125	0.00373	CcSEcCtD
Testosterone Propionate—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00124	0.00369	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00122	0.00364	CcSEcCtD
Testosterone Propionate—Asthenia—Sorafenib—thyroid cancer	0.00122	0.00364	CcSEcCtD
Testosterone Propionate—Pruritus—Sorafenib—thyroid cancer	0.0012	0.00359	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TPR—thyroid cancer	0.00119	0.0114	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.00118	0.00353	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Epirubicin—thyroid cancer	0.00118	0.00352	CcSEcCtD
Testosterone Propionate—Diarrhoea—Sorafenib—thyroid cancer	0.00116	0.00347	CcSEcCtD
Testosterone Propionate—Breast disorder—Epirubicin—thyroid cancer	0.00115	0.00344	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00114	0.0109	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00112	0.0108	CbGpPWpGaD
Testosterone Propionate—Dizziness—Sorafenib—thyroid cancer	0.00112	0.00335	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00109	0.00326	CcSEcCtD
Testosterone Propionate—Vomiting—Sorafenib—thyroid cancer	0.00108	0.00322	CcSEcCtD
Testosterone Propionate—Rash—Sorafenib—thyroid cancer	0.00107	0.0032	CcSEcCtD
Testosterone Propionate—Dermatitis—Sorafenib—thyroid cancer	0.00107	0.00319	CcSEcCtD
Testosterone Propionate—Breast disorder—Doxorubicin—thyroid cancer	0.00107	0.00319	CcSEcCtD
Testosterone Propionate—Headache—Sorafenib—thyroid cancer	0.00106	0.00318	CcSEcCtD
Testosterone Propionate—Dysuria—Epirubicin—thyroid cancer	0.00103	0.00308	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00102	0.00973	CbGpPWpGaD
Testosterone Propionate—Nausea—Sorafenib—thyroid cancer	0.00101	0.00301	CcSEcCtD
Testosterone Propionate—Weight increased—Epirubicin—thyroid cancer	0.001	0.003	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—TRIM33—thyroid cancer	0.001	0.00959	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—RXRA—thyroid cancer	0.000999	0.00956	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—thyroid cancer	0.000965	0.00923	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—RXRA—thyroid cancer	0.000957	0.00915	CbGpPWpGaD
Testosterone Propionate—Dysuria—Doxorubicin—thyroid cancer	0.000954	0.00285	CcSEcCtD
Testosterone Propionate—Haematuria—Epirubicin—thyroid cancer	0.000938	0.0028	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00093	0.00278	CcSEcCtD
Testosterone Propionate—Weight increased—Doxorubicin—thyroid cancer	0.000929	0.00277	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000901	0.00862	CbGpPWpGaD
Testosterone Propionate—Haemoglobin—Epirubicin—thyroid cancer	0.000887	0.00265	CcSEcCtD
Testosterone Propionate—Haemorrhage—Epirubicin—thyroid cancer	0.000883	0.00264	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Epirubicin—thyroid cancer	0.000872	0.0026	CcSEcCtD
Testosterone Propionate—Haematuria—Doxorubicin—thyroid cancer	0.000868	0.00259	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Epirubicin—thyroid cancer	0.000868	0.00259	CcSEcCtD
Testosterone Propionate—Urethral disorder—Epirubicin—thyroid cancer	0.000866	0.00258	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000861	0.00257	CcSEcCtD
Testosterone Propionate—Haemoglobin—Doxorubicin—thyroid cancer	0.000821	0.00245	CcSEcCtD
Testosterone Propionate—Haemorrhage—Doxorubicin—thyroid cancer	0.000817	0.00244	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—SLC5A5—thyroid cancer	0.000812	0.00777	CbGpPWpGaD
Testosterone Propionate—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000807	0.00241	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000803	0.0024	CcSEcCtD
Testosterone Propionate—Angiopathy—Epirubicin—thyroid cancer	0.000801	0.00239	CcSEcCtD
Testosterone Propionate—Urethral disorder—Doxorubicin—thyroid cancer	0.000801	0.00239	CcSEcCtD
Testosterone Propionate—Immune system disorder—Epirubicin—thyroid cancer	0.000798	0.00238	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Epirubicin—thyroid cancer	0.000796	0.00238	CcSEcCtD
Testosterone Propionate—Alopecia—Epirubicin—thyroid cancer	0.00078	0.00233	CcSEcCtD
Testosterone Propionate—Mental disorder—Epirubicin—thyroid cancer	0.000774	0.00231	CcSEcCtD
Testosterone Propionate—Malnutrition—Epirubicin—thyroid cancer	0.000769	0.0023	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—HRAS—thyroid cancer	0.00075	0.00718	CbGpPWpGaD
Testosterone Propionate—Angiopathy—Doxorubicin—thyroid cancer	0.000741	0.00221	CcSEcCtD
Testosterone Propionate—Immune system disorder—Doxorubicin—thyroid cancer	0.000738	0.0022	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000736	0.0022	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—MINPP1—thyroid cancer	0.000734	0.00702	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—THRB—thyroid cancer	0.000724	0.00693	CbGpPWpGaD
Testosterone Propionate—Alopecia—Doxorubicin—thyroid cancer	0.000722	0.00216	CcSEcCtD
Testosterone Propionate—Mental disorder—Doxorubicin—thyroid cancer	0.000716	0.00214	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Epirubicin—thyroid cancer	0.000713	0.00213	CcSEcCtD
Testosterone Propionate—Malnutrition—Doxorubicin—thyroid cancer	0.000711	0.00212	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—MINPP1—thyroid cancer	0.000703	0.00672	CbGpPWpGaD
Testosterone Propionate—Malaise—Epirubicin—thyroid cancer	0.000693	0.00207	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CCND1—thyroid cancer	0.000693	0.00663	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—RXRA—thyroid cancer	0.000682	0.00653	CbGpPWpGaD
Testosterone Propionate—Hypertension—Epirubicin—thyroid cancer	0.000664	0.00198	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—AKT1—thyroid cancer	0.000662	0.00634	CbGpPWpGaD
Testosterone Propionate—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00066	0.00197	CcSEcCtD
Testosterone Propionate—Arthralgia—Epirubicin—thyroid cancer	0.000654	0.00195	CcSEcCtD
Testosterone Propionate—Myalgia—Epirubicin—thyroid cancer	0.000654	0.00195	CcSEcCtD
Testosterone Propionate—Anxiety—Epirubicin—thyroid cancer	0.000652	0.00195	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00065	0.00194	CcSEcCtD
Testosterone Propionate—Discomfort—Epirubicin—thyroid cancer	0.000647	0.00193	CcSEcCtD
Testosterone Propionate—Malaise—Doxorubicin—thyroid cancer	0.000641	0.00192	CcSEcCtD
Testosterone Propionate—Confusional state—Epirubicin—thyroid cancer	0.000633	0.00189	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Epirubicin—thyroid cancer	0.000627	0.00187	CcSEcCtD
Testosterone Propionate—Oedema—Epirubicin—thyroid cancer	0.000627	0.00187	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—NDUFA13—thyroid cancer	0.000624	0.00597	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000619	0.00593	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Epirubicin—thyroid cancer	0.000615	0.00184	CcSEcCtD
Testosterone Propionate—Hypertension—Doxorubicin—thyroid cancer	0.000614	0.00183	CcSEcCtD
Testosterone Propionate—Skin disorder—Epirubicin—thyroid cancer	0.000609	0.00182	CcSEcCtD
Testosterone Propionate—Arthralgia—Doxorubicin—thyroid cancer	0.000605	0.00181	CcSEcCtD
Testosterone Propionate—Myalgia—Doxorubicin—thyroid cancer	0.000605	0.00181	CcSEcCtD
Testosterone Propionate—Anxiety—Doxorubicin—thyroid cancer	0.000603	0.0018	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000601	0.0018	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—RXRA—thyroid cancer	0.000598	0.00573	CbGpPWpGaD
Testosterone Propionate—Discomfort—Doxorubicin—thyroid cancer	0.000598	0.00179	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—NDUFA13—thyroid cancer	0.000598	0.00572	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—NRG1—thyroid cancer	0.00059	0.00565	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CHST14—thyroid cancer	0.000587	0.00561	CbGpPWpGaD
Testosterone Propionate—Confusional state—Doxorubicin—thyroid cancer	0.000585	0.00175	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00058	0.00173	CcSEcCtD
Testosterone Propionate—Oedema—Doxorubicin—thyroid cancer	0.00058	0.00173	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000572	0.00171	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Doxorubicin—thyroid cancer	0.000569	0.0017	CcSEcCtD
Testosterone Propionate—Insomnia—Epirubicin—thyroid cancer	0.000567	0.00169	CcSEcCtD
Testosterone Propionate—Skin disorder—Doxorubicin—thyroid cancer	0.000564	0.00168	CcSEcCtD
Testosterone Propionate—Paraesthesia—Epirubicin—thyroid cancer	0.000563	0.00168	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—CHST14—thyroid cancer	0.000562	0.00538	CbGpPWpGaD
Testosterone Propionate—Dyspnoea—Epirubicin—thyroid cancer	0.000559	0.00167	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—thyroid cancer	0.000558	0.00534	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000544	0.00521	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000542	0.00162	CcSEcCtD
Testosterone Propionate—Fatigue—Epirubicin—thyroid cancer	0.000541	0.00162	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000541	0.00517	CbGpPWpGaD
Testosterone Propionate—Pain—Epirubicin—thyroid cancer	0.000536	0.0016	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000529	0.00158	CcSEcCtD
Testosterone Propionate—Insomnia—Doxorubicin—thyroid cancer	0.000525	0.00157	CcSEcCtD
Testosterone Propionate—Paraesthesia—Doxorubicin—thyroid cancer	0.000521	0.00156	CcSEcCtD
Testosterone Propionate—Dyspnoea—Doxorubicin—thyroid cancer	0.000517	0.00155	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Epirubicin—thyroid cancer	0.000517	0.00154	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000513	0.00153	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CCND1—thyroid cancer	0.000512	0.0049	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000501	0.0015	CcSEcCtD
Testosterone Propionate—Fatigue—Doxorubicin—thyroid cancer	0.0005	0.00149	CcSEcCtD
Testosterone Propionate—Urticaria—Epirubicin—thyroid cancer	0.000498	0.00149	CcSEcCtD
Testosterone Propionate—Pain—Doxorubicin—thyroid cancer	0.000496	0.00148	CcSEcCtD
Testosterone Propionate—Abdominal pain—Epirubicin—thyroid cancer	0.000496	0.00148	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—PTEN—thyroid cancer	0.000494	0.00473	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—TRIM33—thyroid cancer	0.000482	0.00461	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Doxorubicin—thyroid cancer	0.000478	0.00143	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000475	0.00142	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—HPGD—thyroid cancer	0.000473	0.00453	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Epirubicin—thyroid cancer	0.000462	0.00138	CcSEcCtD
Testosterone Propionate—Urticaria—Doxorubicin—thyroid cancer	0.000461	0.00138	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—MEN1—thyroid cancer	0.00046	0.0044	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.00046	0.0044	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Doxorubicin—thyroid cancer	0.000459	0.00137	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—HPGD—thyroid cancer	0.000453	0.00433	CbGpPWpGaD
Testosterone Propionate—Asthenia—Epirubicin—thyroid cancer	0.00045	0.00134	CcSEcCtD
Testosterone Propionate—Pruritus—Epirubicin—thyroid cancer	0.000444	0.00133	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—MINPP1—thyroid cancer	0.00044	0.00421	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Epirubicin—thyroid cancer	0.000429	0.00128	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Doxorubicin—thyroid cancer	0.000428	0.00128	CcSEcCtD
Testosterone Propionate—COMT—Neuronal System—BRAF—thyroid cancer	0.000417	0.00399	CbGpPWpGaD
Testosterone Propionate—Asthenia—Doxorubicin—thyroid cancer	0.000416	0.00124	CcSEcCtD
Testosterone Propionate—Dizziness—Epirubicin—thyroid cancer	0.000415	0.00124	CcSEcCtD
Testosterone Propionate—Pruritus—Doxorubicin—thyroid cancer	0.000411	0.00123	CcSEcCtD
Testosterone Propionate—Vomiting—Epirubicin—thyroid cancer	0.000399	0.00119	CcSEcCtD
Testosterone Propionate—Diarrhoea—Doxorubicin—thyroid cancer	0.000397	0.00119	CcSEcCtD
Testosterone Propionate—Rash—Epirubicin—thyroid cancer	0.000396	0.00118	CcSEcCtD
Testosterone Propionate—Dermatitis—Epirubicin—thyroid cancer	0.000395	0.00118	CcSEcCtD
Testosterone Propionate—Headache—Epirubicin—thyroid cancer	0.000393	0.00117	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—AKT1—thyroid cancer	0.000385	0.00369	CbGpPWpGaD
Testosterone Propionate—Dizziness—Doxorubicin—thyroid cancer	0.000384	0.00115	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—NDUFA13—thyroid cancer	0.000374	0.00358	CbGpPWpGaD
Testosterone Propionate—Nausea—Epirubicin—thyroid cancer	0.000373	0.00111	CcSEcCtD
Testosterone Propionate—Vomiting—Doxorubicin—thyroid cancer	0.000369	0.0011	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000367	0.00351	CbGpPWpGaD
Testosterone Propionate—Rash—Doxorubicin—thyroid cancer	0.000366	0.00109	CcSEcCtD
Testosterone Propionate—Dermatitis—Doxorubicin—thyroid cancer	0.000366	0.00109	CcSEcCtD
Testosterone Propionate—Headache—Doxorubicin—thyroid cancer	0.000364	0.00109	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—CHST14—thyroid cancer	0.000351	0.00336	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—THRB—thyroid cancer	0.000349	0.00334	CbGpPWpGaD
Testosterone Propionate—Nausea—Doxorubicin—thyroid cancer	0.000345	0.00103	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000335	0.00321	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000324	0.0031	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—RXRA—thyroid cancer	0.000308	0.00294	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000308	0.00294	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000307	0.00294	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—AKT1—thyroid cancer	0.000285	0.00273	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—HPGD—thyroid cancer	0.000283	0.00271	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000278	0.00266	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—TPR—thyroid cancer	0.000272	0.0026	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000268	0.00257	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PRKAR1A—thyroid cancer	0.000267	0.00256	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—TPR—thyroid cancer	0.00026	0.00249	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PRKAR1A—thyroid cancer	0.000256	0.00245	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.00025	0.0024	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000249	0.00238	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—TPR—thyroid cancer	0.000236	0.00225	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000232	0.00222	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MEN1—thyroid cancer	0.000221	0.00212	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000221	0.00211	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000206	0.00197	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SLC5A5—thyroid cancer	0.000203	0.00195	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—SLC5A5—thyroid cancer	0.000195	0.00186	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—PPARG—thyroid cancer	0.000194	0.00186	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—HRAS—thyroid cancer	0.000192	0.00184	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	0.000187	0.00179	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000183	0.00175	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000182	0.00175	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—RXRA—thyroid cancer	0.000171	0.00163	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—RXRA—thyroid cancer	0.000164	0.00157	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—TPR—thyroid cancer	0.000163	0.00156	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PRKAR1A—thyroid cancer	0.00016	0.00153	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000159	0.00152	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000155	0.00148	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—RXRA—thyroid cancer	0.000148	0.00142	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—SLC5A5—thyroid cancer	0.000122	0.00117	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PPARG—thyroid cancer	0.000108	0.00103	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PPARG—thyroid cancer	0.000103	0.000988	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—RXRA—thyroid cancer	0.000102	0.000979	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PPARG—thyroid cancer	9.35e-05	0.000895	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTGS2—thyroid cancer	8.49e-05	0.000812	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTGS2—thyroid cancer	8.13e-05	0.000778	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTEN—thyroid cancer	7.4e-05	0.000708	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTEN—thyroid cancer	7.09e-05	0.000678	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PPARG—thyroid cancer	6.46e-05	0.000618	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTGS2—thyroid cancer	5.08e-05	0.000486	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTEN—thyroid cancer	4.43e-05	0.000424	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—AKT1—thyroid cancer	4.26e-05	0.000408	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—AKT1—thyroid cancer	4.08e-05	0.000391	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—AKT1—thyroid cancer	3.7e-05	0.000354	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—AKT1—thyroid cancer	2.55e-05	0.000244	CbGpPWpGaD
